Pharmacokinetic and pharmacodynamic issues in the treatment of breakthrough pain.
Cleary
J F
JF
Department of Medicine, University of Wisconsin Comprehensive Cancer Center, University of Wisconsin Hospital and Clinics, Madison, USA.
D000279:Administration, Cutaneous; D000281:Administration, Intranasal; D000284:Administration, Oral; D000286:Administration, Sublingual; D001682:Biological Availability; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D009020:Morphine / Q000008:administration & dosage; D009294:Narcotics / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010146:Pain / Q000188:drug therapy*
D009294:Narcotics; D009020:Morphine; D005283:Fentanyl